Royalty Pharma (RPRX)
NASDAQ: RPRX
· Real-Time Price · USD
36.34
-0.16 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
36.08
-0.72%
After-hours: Aug 15, 2025, 07:21 PM EDT
Royalty Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 30.18M | 433.43M | 334.35M | 806.36M | 194.38M | -4.27M | 717.59M | 122.08M | 351.34M | 509.09M | -610.03M | 220.41M | 491.6M | 128.08M | 53.67M | 221.8M | 806.75M | 158.98M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.67M | 5.8M | 5.8M | 5.73M | 5.67M |
Stock-Based Compensation | -515K | 515K | 525K | 526K | 681K | 612K | 617K | 581K | 586K | 573K | 583K | 582K | 509K | 496K | 504K | 505K | 721K | 713K |
Other Working Capital | 786.57M | -77.73M | 59.45M | -24.61M | 51.44M | -26.06M | 42.06M | -38.13M | 35.31M | -40.69M | 34.91M | -35.42M | 42.43M | -43.26M | 43.29M | -33.08M | 37.13M | -29.94M |
Other Non-Cash Items | -379.42M | 226.6M | 356.13M | -84.55M | 413.07M | 697.79M | 6.51M | 487.88M | 218.26M | 567.31M | 1.15B | 348.81M | 4.44M | 365.73M | 383.95M | 304.63M | -315.07M | 393.71M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 776.22M | -64.48M | 51.52M | -18.72M | 50.08M | -29.5M | 47.91M | -37.02M | 37.63M | -43.14M | 24.95M | -30.98M | 78.41M | -39.71M | 46.04M | -62.97M | 33.58M | -32.97M |
Operating Cash Flow | 426.97M | 596.08M | 742.52M | 703.61M | 658.21M | 664.64M | 772.63M | 573.52M | 607.82M | 1.03B | 569.93M | 538.83M | 574.95M | 460.27M | 489.96M | 469.76M | 531.72M | 526.1M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | -69.37M | n/a | n/a | n/a | -3.98M | -6.97M | -1.99M | -3.98M | -2.99M | -3.58M | n/a | -6.85M | n/a | -3.05M | -6.54M | -10.89M | -8.71M | -8.71M |
Purchase of Investments | -75M | -5.48M | -496.42M | -1.21B | -946.63M | -86.08M | -1B | -451.13M | -60.45M | -601.71M | -361.06M | -1.63B | -297.1M | -276.02M | -665.45M | -1.48B | -420.94M | -1.03B |
Sales Maturities Of Investments | 2.88M | 523.14M | 12.59M | 2.88M | 101.45M | 1.44M | 1.44M | n/a | n/a | 24.39M | 775.8M | 212.58M | 266.92M | 290.23M | 120.34M | 646.66M | 573.9M | 435.41M |
Other Investing Acitivies | -227.55M | -13.74M | -21.76M | 11.49M | -44.02M | 4.96M | 2.62M | 4.46M | n/a | 22.37M | n/a | n/a | n/a | n/a | n/a | n/a | -18.08M | n/a |
Investing Cash Flow | -370.15M | 503.92M | -505.59M | -1.19B | -893.18M | -86.65M | -1B | -450.66M | -63.43M | -558.53M | 414.74M | -1.43B | -30.18M | 11.16M | -551.65M | -845.5M | 126.17M | -599.3M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.27B | n/a | n/a |
Common Stock Repurchased | -291.57M | -708.78M | -52.61M | -97.05M | -80M | n/a | -30.2M | -140.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -93.24M | -95.36M | -93.66M | -94.06M | -94.94M | -93.81M | -89.34M | -89.75M | -90.61M | -88.63M | -84.2M | -83.81M | -83.05M | -82.26M | -73.6M | -73.02M | -72.58M | -65.98M |
Other Financial Acitivies | -127.83M | -137.16M | -111.7M | -134.4M | 1.33B | -118.19M | -112.36M | -129.62M | -256.39M | -121.74M | -181.35M | -146.28M | -145.21M | -138.7M | -124.47M | -165.25M | -151.83M | -160.69M |
Financial Cash Flow | -512.64M | -941.3M | -257.96M | -325.5M | 1.16B | -212M | -231.89M | -1.36B | -347M | -210.37M | -265.55M | -230.09M | -228.25M | -220.97M | -198.07M | 1.03B | -224.41M | -226.67M |
Net Cash Flow | -455.81M | 158.69M | -21.03M | -814.59M | 921.64M | 365.99M | -459.44M | -1.24B | 197.39M | 264.94M | 719.12M | -1.12B | 316.52M | 250.47M | -259.76M | 658.53M | 433.47M | -299.87M |
Free Cash Flow | 426.97M | 596.08M | 742.52M | 703.61M | 658.21M | 664.64M | 772.63M | 573.52M | 607.82M | 1.03B | 569.93M | 538.83M | 574.95M | 460.27M | 489.96M | 469.76M | 531.72M | 526.1M |